C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/06 (2006.01) A61K 31/4178 (2006.01) A61K 31/4439 (2006.01) A61P 9/00 (2006.01) C07D 401/14 (2006.01) C07D 403/06 (2006.01) C07D 405/14 (2006.01)
Patent
CA 2691662
The invention is concerned with novel imidazole derivatives of formula (I), wherein (Ia), m, E, R1, R2, R3, R4, R5, R6 and R7 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds are antagonists of CCR- 2 receptor, CCR-5 receptor and/or CCR-3 receptor and can be used as medicaments.
L'invention concerne de nouveaux dérivés imidazolés de formule (I), dans laquelle m, E, R1, R2, R3, R4, R5, R6 et R7 sont tels que définis dans la description et dans les revendications, ainsi que des sels physiologiquement acceptables desdits dérivés. Ces composés sont des antagonistes du récepteur CCR-2, du récepteur CCR-5 et/ou du récepteur CCR-3 et peuvent être utilisés comme médicaments.
Aebi Johannes
Binggeli Alfred
Green Luke
Hartmann Guido
Maerki Hans P.
F. Hoffmann-La Roche Ag
Gowling Lafleur Henderson Llp
LandOfFree
Imidazole derivatives as ccr2 receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazole derivatives as ccr2 receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazole derivatives as ccr2 receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1862101